BPC157, TB500, GHK Cu FDA The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. Mitigating Risks of Compounded Drugs Through Surveillance FDA FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Risk Control Safety Assessment ELSIE Consortium